Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Dec;14(12):1164-1176.
doi: 10.1080/15592294.2019.1640546. Epub 2019 Jul 13.

Epidrugs: targeting epigenetic marks in cancer treatment

Cristiana Libardi Miranda Furtado  1 , Maria Claudia Dos Santos Luciano  2 , Renan Da Silva Santos  2 , Gilvan Pessoa Furtado  3 , Manoel Odorico Moraes  1   2 , Claudia Pessoa  2
Affiliations
Review

Epidrugs: targeting epigenetic marks in cancer treatment

Cristiana Libardi Miranda Furtado et al. Epigenetics. 2019 Dec.

Abstract

Growing evidence suggests that aberrant epigenetic regulation of gene function is strongly related to the genesis of cancer. Unlike genetic mutations, the ability to reprogram the epigenetic landscape in the cancer epigenome is one of the most promising target therapies in both treatment and reversibility of drug resistance. Epigenetic alterations in cancer development and progression may be the basis for the individual variation in drug response. Thus, this review focuses on the emerging area of pharmaco(epi)genomics, specifically highlighting epigenetic reprogramming during tumorigenesis and how epigenetic markers are targeted as a therapy (epidrugs) and the clinical implications of this for cancer treatment.

Keywords: Epigenetics; cancer; epidrugs; pharmacology; reprogramming; treatment.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic representation of epigenetic modifications and epidrugs action. The modification of cytosine to 5-methylcytosine (5mC) DNA methylation is catalyzed by DNA methyltransferases (DNMTs). DNMTs require S-Adenosylmethionine (SAM) as a cofactor for methyl group donation that is converted to S-adenosylhomocysteine (SAH). DNA methylation at a promoter region is related to transcriptional silencing. The DNMT inhibitors (DNMTi) block DNA methylation and restore the function of aberrantly silenced genes. At the chromatin level, histone post-translational acetylation is catalyzed by histone acetyltransferases (HATs) and deacetylation by histone deacetylases (HDACs). Such modifications occur into amino acid residues (such as lysine) at histone tails. HDAC inhibitors (HDACi) induce the acetylation, an epigenetic modification associated with transcriptional activation and gene expression
Figure 2.
Figure 2.
Progress of epigenetic drugs in different stages of pharmacological studies. The number of epigenetic studies from 2009 to 2019 according to ‘web of science’ database is showed according to each study phase: in vitro (1217) in vivo (952), preclinical (465) and clinical (137). The map represents the global distribution of clinical epigenetic drug studies according to clinical trial database (www.clinicaltrial.org, june, 2019), and the box show the exact number of studies.
See this image and copyright information in PMC

References

    1. Horike S, Mitsuya K, Meguro M, et al. Targeted disruption of the human LIT1 locus defines a putative imprinting control element playing an essential role in Beckwith-Wiedemann syndrome. Hum Mol Genet. 2000;9:2075–2083. - PubMed
    1. Eggermann T, Schönherr N, Meyer E, et al. Epigenetic mutations in 11p15 in Silver-Russell syndrome are restricted to the telomeric imprinting domain. J Med Genet. 2006;43:615–616. - PMC - PubMed
    1. Buiting K. Prader-Willi syndrome and Angelman syndrome. Am J Med Genet C Semin Med Genet. 2010;154C:365–376. - PubMed
    1. Murphy SK, Jirtle RL. Imprinting evolution and the price of silence. BioEssays. 2003;25:577–588. - PubMed
    1. Das R, Hampton DD, Jirtle RL. Imprinting evolution and human health. Mamm Genome. 2009;20:563–572. - PubMed

Publication types

Substances